Neurotechnology is any technology that has a fundamental influence on how people understand the brain and various aspects of consciousness, thought, and higher order activities in the brain. It also includes technologies that are designed to improve and repair brain function and allow researchers and clinicians to visualize the brain. The digital health sector matures from basic tracking apps into highly regulated medical devices, right now there is a bleeding edge technologies being developed that blur the lines between computers and biology and a growing share of these startups are beginning to target the brain. The burgeoning field of neurotechnology involves brain-machine interfaces, neuroproteins, neurostimulation, neuromonitoring, and implantable devices intended to not only augment nervous system activity, but expand its capabilities.
The global Neurotechnology Device market was valued at US$ 10980 million in 2023 and is anticipated to reach US$ 18330 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.
The global neurotechnology device market refers to the industry involved in the development, manufacturing, distribution, and usage of devices and technologies that are used in the diagnosis, treatment, and management of neurological disorders and conditions. Neurotechnology devices encompass a wide range of products, including neurostimulation devices, neurofeedback devices, brain-computer interfaces, neurodiagnostic devices, and neuroprosthetics. Here鈥檚 an overview of the market:
麻豆原创 Overview: The neurotechnology device market is a rapidly growing sector within the broader medical device industry. It encompasses a diverse range of devices and technologies that aim to understand brain function, diagnose neurological disorders, and provide therapeutic interventions for various neurological conditions.
麻豆原创 Segmentation: The market can be segmented based on the type of device, including neurostimulation devices (such as deep brain stimulation, spinal cord stimulation, and transcranial magnetic stimulation devices), neurofeedback devices, brain-computer interfaces, neurodiagnostic devices (such as EEG, MRI, and CT scanning), and neuroprosthetics (such as cochlear implants and deep brain implants).
Neurological Conditions: Neurotechnology devices are used in the diagnosis and treatment of various neurological conditions, including epilepsy, Parkinson鈥檚 disease, Alzheimer鈥檚 disease, stroke, chronic pain, depression, and others. These devices aim to improve patient outcomes, enhance quality of life, and potentially restore lost neurological function.
Technological Advancements: Advances in neuroscience, neuroimaging, computational algorithms, and miniaturization of devices have contributed to the rapid growth of the neurotechnology market. Innovations in neurostimulation techniques, real-time brain monitoring, wearable and implantable devices, and neurofeedback technologies are driving market expansion.
Key Players: The neurotechnology device market is highly competitive, with several established companies and emerging startups operating in the field. Key players include Medtronic, Abbott Laboratories, Boston Scientific, Cochlear Limited, NeuroPace, and others. These companies invest in research and development, clinical trials, and marketing to introduce new and improved neurotechnology devices.
麻豆原创 Dynamics: Factors such as increasing prevalence of neurological disorders, growing aging population, rising awareness, technological advancements, and favorable reimbursement policies are driving the market growth. However, challenges such as high costs associated with devices, stringent regulatory processes, and ethical considerations in brain-computer interface technology can affect market progression.
麻豆原创 Outlook: The global neurotechnology device market is expected to continue its growth trajectory in the coming years. Increasing investments in research and development, collaborations between academia and industry, and the focus on personalized medicine are likely to drive innovation and the introduction of advanced neurotechnology devices.
Ethical and Regulatory Considerations: The use of neurotechnology devices raises ethical concerns related to data privacy, informed consent, and potential misuse. Regulatory agencies closely monitor the safety and efficacy of these devices, ensuring adherence to quality standards and ethical principles.
This report aims to provide a comprehensive presentation of the global market for Neurotechnology Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurotechnology Device.
Report Scope
The Neurotechnology Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurotechnology Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurotechnology Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Abbott Laboratories
Advanced Bionics
Axonics Modulation Technologies
Boston Scientific Corp
Laborie
Cleveland Medical Devices
EndoStim
LivaNova
Medtronic
Natus Medical Incorporated
Neuronetics
NeuroSigma
Restorative Therapies
Zynex Medical
Cochlear Limited
Segment by Type
Neuroprosthetics
Neural Stimulators
Neurorehabilitation
Neurosensing
Segment by Application
Parkinson's Disease
Cerebral Palsy
Cognitive Disorders
Epilepsy
Incontinence
Traumatic Brain Injury
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neurotechnology Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neurotechnology Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Neurotechnology Device 麻豆原创 Overview
1.1 Product Overview and Scope of Neurotechnology Device
1.2 Neurotechnology Device Segment by Type
1.2.1 Global Neurotechnology Device 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Neuroprosthetics
1.2.3 Neural Stimulators
1.2.4 Neurorehabilitation
1.2.5 Neurosensing
1.3 Neurotechnology Device Segment by Application
1.3.1 Global Neurotechnology Device 麻豆原创 Value by Application: (2024-2030)
1.3.2 Parkinson's Disease
1.3.3 Cerebral Palsy
1.3.4 Cognitive Disorders
1.3.5 Epilepsy
1.3.6 Incontinence
1.3.7 Traumatic Brain Injury
1.3.8 Others
1.4 Global Neurotechnology Device 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Neurotechnology Device Revenue 2019-2030
1.4.2 Global Neurotechnology Device Sales 2019-2030
1.4.3 Global Neurotechnology Device 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Neurotechnology Device 麻豆原创 Competition by Manufacturers
2.1 Global Neurotechnology Device Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Neurotechnology Device Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Neurotechnology Device Average Price by Manufacturers (2019-2024)
2.4 Global Neurotechnology Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neurotechnology Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurotechnology Device, Product Type & Application
2.7 Neurotechnology Device 麻豆原创 Competitive Situation and Trends
2.7.1 Neurotechnology Device 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neurotechnology Device Players 麻豆原创 Share by Revenue
2.7.3 Global Neurotechnology Device 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neurotechnology Device Retrospective 麻豆原创 Scenario by Region
3.1 Global Neurotechnology Device 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Neurotechnology Device Global Neurotechnology Device Sales by Region: 2019-2030
3.2.1 Global Neurotechnology Device Sales by Region: 2019-2024
3.2.2 Global Neurotechnology Device Sales by Region: 2025-2030
3.3 Global Neurotechnology Device Global Neurotechnology Device Revenue by Region: 2019-2030
3.3.1 Global Neurotechnology Device Revenue by Region: 2019-2024
3.3.2 Global Neurotechnology Device Revenue by Region: 2025-2030
3.4 North America Neurotechnology Device 麻豆原创 Facts & Figures by Country
3.4.1 North America Neurotechnology Device 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Neurotechnology Device Sales by Country (2019-2030)
3.4.3 North America Neurotechnology Device Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Neurotechnology Device 麻豆原创 Facts & Figures by Country
3.5.1 Europe Neurotechnology Device 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Neurotechnology Device Sales by Country (2019-2030)
3.5.3 Europe Neurotechnology Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurotechnology Device 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Neurotechnology Device 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Neurotechnology Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Neurotechnology Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Neurotechnology Device 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Neurotechnology Device 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Neurotechnology Device Sales by Country (2019-2030)
3.7.3 Latin America Neurotechnology Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Neurotechnology Device 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Neurotechnology Device 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Neurotechnology Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Neurotechnology Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neurotechnology Device Sales by Type (2019-2030)
4.1.1 Global Neurotechnology Device Sales by Type (2019-2024)
4.1.2 Global Neurotechnology Device Sales by Type (2025-2030)
4.1.3 Global Neurotechnology Device Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Neurotechnology Device Revenue by Type (2019-2030)
4.2.1 Global Neurotechnology Device Revenue by Type (2019-2024)
4.2.2 Global Neurotechnology Device Revenue by Type (2025-2030)
4.2.3 Global Neurotechnology Device Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Neurotechnology Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Neurotechnology Device Sales by Application (2019-2030)
5.1.1 Global Neurotechnology Device Sales by Application (2019-2024)
5.1.2 Global Neurotechnology Device Sales by Application (2025-2030)
5.1.3 Global Neurotechnology Device Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Neurotechnology Device Revenue by Application (2019-2030)
5.2.1 Global Neurotechnology Device Revenue by Application (2019-2024)
5.2.2 Global Neurotechnology Device Revenue by Application (2025-2030)
5.2.3 Global Neurotechnology Device Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Neurotechnology Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Neurotechnology Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Laboratories Neurotechnology Device Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Advanced Bionics
6.2.1 Advanced Bionics Corporation Information
6.2.2 Advanced Bionics Description and Business Overview
6.2.3 Advanced Bionics Neurotechnology Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Advanced Bionics Neurotechnology Device Product Portfolio
6.2.5 Advanced Bionics Recent Developments/Updates
6.3 Axonics Modulation Technologies
6.3.1 Axonics Modulation Technologies Corporation Information
6.3.2 Axonics Modulation Technologies Description and Business Overview
6.3.3 Axonics Modulation Technologies Neurotechnology Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Axonics Modulation Technologies Neurotechnology Device Product Portfolio
6.3.5 Axonics Modulation Technologies Recent Developments/Updates
6.4 Boston Scientific Corp
6.4.1 Boston Scientific Corp Corporation Information
6.4.2 Boston Scientific Corp Description and Business Overview
6.4.3 Boston Scientific Corp Neurotechnology Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Boston Scientific Corp Neurotechnology Device Product Portfolio
6.4.5 Boston Scientific Corp Recent Developments/Updates
6.5 Laborie
6.5.1 Laborie Corporation Information
6.5.2 Laborie Description and Business Overview
6.5.3 Laborie Neurotechnology Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Laborie Neurotechnology Device Product Portfolio
6.5.5 Laborie Recent Developments/Updates
6.6 Cleveland Medical Devices
6.6.1 Cleveland Medical Devices Corporation Information
6.6.2 Cleveland Medical Devices Description and Business Overview
6.6.3 Cleveland Medical Devices Neurotechnology Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cleveland Medical Devices Neurotechnology Device Product Portfolio
6.6.5 Cleveland Medical Devices Recent Developments/Updates
6.7 EndoStim
6.6.1 EndoStim Corporation Information
6.6.2 EndoStim Description and Business Overview
6.6.3 EndoStim Neurotechnology Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 EndoStim Neurotechnology Device Product Portfolio
6.7.5 EndoStim Recent Developments/Updates
6.8 LivaNova
6.8.1 LivaNova Corporation Information
6.8.2 LivaNova Description and Business Overview
6.8.3 LivaNova Neurotechnology Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 LivaNova Neurotechnology Device Product Portfolio
6.8.5 LivaNova Recent Developments/Updates
6.9 Medtronic
6.9.1 Medtronic Corporation Information
6.9.2 Medtronic Description and Business Overview
6.9.3 Medtronic Neurotechnology Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Medtronic Neurotechnology Device Product Portfolio
6.9.5 Medtronic Recent Developments/Updates
6.10 Natus Medical Incorporated
6.10.1 Natus Medical Incorporated Corporation Information
6.10.2 Natus Medical Incorporated Description and Business Overview
6.10.3 Natus Medical Incorporated Neurotechnology Device Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Natus Medical Incorporated Neurotechnology Device Product Portfolio
6.10.5 Natus Medical Incorporated Recent Developments/Updates
6.11 Neuronetics
6.11.1 Neuronetics Corporation Information
6.11.2 Neuronetics Neurotechnology Device Description and Business Overview
6.11.3 Neuronetics Neurotechnology Device Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Neuronetics Neurotechnology Device Product Portfolio
6.11.5 Neuronetics Recent Developments/Updates
6.12 NeuroSigma
6.12.1 NeuroSigma Corporation Information
6.12.2 NeuroSigma Neurotechnology Device Description and Business Overview
6.12.3 NeuroSigma Neurotechnology Device Sales, Revenue and Gross Margin (2019-2024)
6.12.4 NeuroSigma Neurotechnology Device Product Portfolio
6.12.5 NeuroSigma Recent Developments/Updates
6.13 Restorative Therapies
6.13.1 Restorative Therapies Corporation Information
6.13.2 Restorative Therapies Neurotechnology Device Description and Business Overview
6.13.3 Restorative Therapies Neurotechnology Device Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Restorative Therapies Neurotechnology Device Product Portfolio
6.13.5 Restorative Therapies Recent Developments/Updates
6.14 Zynex Medical
6.14.1 Zynex Medical Corporation Information
6.14.2 Zynex Medical Neurotechnology Device Description and Business Overview
6.14.3 Zynex Medical Neurotechnology Device Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Zynex Medical Neurotechnology Device Product Portfolio
6.14.5 Zynex Medical Recent Developments/Updates
6.15 Cochlear Limited
6.15.1 Cochlear Limited Corporation Information
6.15.2 Cochlear Limited Neurotechnology Device Description and Business Overview
6.15.3 Cochlear Limited Neurotechnology Device Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Cochlear Limited Neurotechnology Device Product Portfolio
6.15.5 Cochlear Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurotechnology Device Industry Chain Analysis
7.2 Neurotechnology Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurotechnology Device Production Mode & Process
7.4 Neurotechnology Device Sales and 麻豆原创ing
7.4.1 Neurotechnology Device Sales Channels
7.4.2 Neurotechnology Device Distributors
7.5 Neurotechnology Device Customers
8 Neurotechnology Device 麻豆原创 Dynamics
8.1 Neurotechnology Device Industry Trends
8.2 Neurotechnology Device 麻豆原创 Drivers
8.3 Neurotechnology Device 麻豆原创 Challenges
8.4 Neurotechnology Device 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Abbott Laboratories
Advanced Bionics
Axonics Modulation Technologies
Boston Scientific Corp
Laborie
Cleveland Medical Devices
EndoStim
LivaNova
Medtronic
Natus Medical Incorporated
Neuronetics
NeuroSigma
Restorative Therapies
Zynex Medical
Cochlear Limited
听
听
*If Applicable.
